Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir Rollover Study for HCV
NCT00535847Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of telaprevir in hepatitis C (HCV), sponsored by Vertex Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00535847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535847.